Drugs / ABBV-950
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT05956509 | Jan → Jun 2024 | — | AbbVie | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ABBV-950 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05956509 ↗ |
| Modality | Protein / enzyme biologic | “Biological: ABBV-950” NCT05956509 ↗ |